Literature DB >> 20362729

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry.

Claire S Duvernoy1, Dean E Smith, Prerana Manohar, Ann Schaefer, Eva Kline-Rogers, David Share, Richard McNamara, Hitinder S Gurm, Mauro Moscucci.   

Abstract

BACKGROUND: Prior studies have shown a relationship between female gender and adverse outcomes after percutaneous coronary interventions (PCIs). Whether this relationship still exists with contemporary PCI remains to be determined.
METHODS: We evaluated gender differences in clinical outcomes in a large registry of contemporary PCI. Data were prospectively collected from 22,725 consecutive PCIs in a multicenter regional consortium (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) between January 2002 and December 2003. The primary end point was in-hospital all-cause mortality; other clinical outcomes evaluated included in-hospital death, vascular complications, transfusion, postprocedure myocardial infarction, stroke, and a combined major cardiovascular adverse event (MACE) end point including myocardial infarction, death, stroke, emergency coronary artery bypass grafting, and repeated PCI at the same site. Independent predictors of adverse outcomes were identified using multivariate logistic regression analysis.
RESULTS: Compared with men, women were older, had a higher prevalence of comorbidities, and had a significantly higher frequency of adverse outcomes after PCI. After adjustment for baseline demographics, comorbidities, clinical presentation, and lesion characteristics, female gender was associated with an increased risk of in-hospital death, vascular complication, blood transfusion, stroke, and MACE. The relationship between female gender and increased risk of death and MACE was no longer present after further adjustment for kidney function and low body surface area.
CONCLUSIONS: Differences in mortality rates between men and women no longer exist after PCI. However, our data suggest that technological advancements have not completely offset the relationship between gender and adverse outcomes after PCI. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20362729     DOI: 10.1016/j.ahj.2009.12.040

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  27 in total

1.  Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.

Authors:  Hideki Wada; Manabu Ogita; Katsumi Miyauchi; Jun Shitara; Hirohisa Endo; Shinichiro Doi; Ryo Naito; Hirokazu Konishi; Shuta Tsuboi; Tomotaka Dohi; Takatoshi Kasai; Hiroshi Tamura; Shinya Okazaki; Kikuo Isoda; Satoru Suwa; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2016-04-23       Impact factor: 2.037

2.  Gender gap in acute coronary heart disease: Myth or reality?

Authors:  Mette Claassen; Kirsten C Sybrandy; Yolande E Appelman; Folkert W Asselbergs
Journal:  World J Cardiol       Date:  2012-02-26

Review 3.  Coronary revascularization in women.

Authors:  Gina Lundberg; Spencer King
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

4.  Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age.

Authors:  Amber M Otten; Angela H E M Maas; Jan Paul Ottervanger; Anita Kloosterman; Arnoud W J van 't Hof; Jan Henk E Dambrink; A T Marcel Gosselink; Jan C A Hoorntje; Harry Suryapranata; Menko Jan de Boer
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-01-31

5.  Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration.

Authors:  Melissa M Farmer; Maggie A Stanislawski; Mary E Plomondon; Bevanne Bean-Mayberry; Nataria T Joseph; Lauren E Thompson; Jessica L Zuchowski; Stacie L Daugherty; Elizabeth M Yano; P Michael Ho
Journal:  J Womens Health (Larchmt)       Date:  2017-05-12       Impact factor: 2.681

6.  Cost-effectiveness of a symptom management intervention: improving physical activity in older women following coronary artery bypass surgery.

Authors:  Lufei Young; Lani Zimmerman; Bunny Pozehl; Susan Barnason; Hongmei Wang
Journal:  Nurs Econ       Date:  2012 Mar-Apr       Impact factor: 1.085

7.  Temporal changes in outcomes of women and men undergoing percutaneous coronary intervention for chronic total occlusion: 2005-2013.

Authors:  Aurel Toma; Barbara E Stähli; Michael Gick; Miroslaw Ferenc; Kambis Mashayekhi; Heinz Joachim Buettner; Franz-Josef Neumann; Catherine Gebhard
Journal:  Clin Res Cardiol       Date:  2018-01-22       Impact factor: 5.460

8.  TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.

Authors:  Connie N Hess; Sunil V Rao; David F Kong; Julie M Miller; Kevin J Anstrom; Olivier F Bertrand; Jean-Philippe Collet; Mark B Effron; Benjamin C Eloff; Emmanuel O Fadiran; Andrew Farb; Ian C Gilchrist; David R Holmes; Alice K Jacobs; Prashant Kaul; L Kristin Newby; David R Rutledge; Dale R Tavris; Thomas T Tsai; Roseann M White; Eric D Peterson; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2013-03       Impact factor: 4.749

9.  Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry.

Authors:  Stacie L Daugherty; Lauren E Thompson; Sunghee Kim; Sunil V Rao; Sumeet Subherwal; Thomas T Tsai; John C Messenger; Frederick A Masoudi
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

10.  In-hospital complications after invasive strategy for the management of Non STEMI: women fare as well as men.

Authors:  Caroline Berthillot; Dominique Stephan; Michel Chauvin; Gerald Roul
Journal:  BMC Cardiovasc Disord       Date:  2010-06-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.